Responses
EULAR 2014: Scientific Abstracts
Poster Presentations. Epidemiology, health services and outcome research
FRI0178 Estimated Medical Expenditures among Patients with Rheumatoid Arthritis Undergoing Treatment with Tofacitinib, an Oral Janus Kinase Inhibitor
Compose a Response to This Article
Other responses
No responses have been published for this article.